Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: An evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin

Journal of Clinical and Aesthetic Dermatology

Volumn 4, Issue 6, 2011, Pages

  Del Rosso, James Q ^a  

^a VALLEY HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA GLUCOCEREBROSIDASE; CATECHIN; CERAMIDASE; CERAMIDE; CETAPHIL; CHOLESTEROL DERIVATIVE; CORTICOSTEROID; DETERGENT; EMOLLIENT AGENT; ENZYME; FILAGGRIN; HUMECTANT; IMMUNOGLOBULIN E; INVOLUCRIN; LINOLEIC ACID; LIPID; NON PRESCRIPTION DRUG; PROPASIN; PROTEIN; SERINE PALITOYL TRANSFERASE; SPHINGOMYELIN DEACYLASE; SPHINGOMYELIN PHOSPHODIESTERASE; STEARIC ACID; UNCLASSIFIED DRUG; VEGETABLE OIL;

ATOPIC DERMATITIS; ATOPY; BODY WASH MOISTURIZER; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EPIDERMIS; EPIDERMIS BARRIER; EVALUATION; GENETIC VARIABILITY; HUMAN; INCIDENCE; INFLAMMATION; LANGERHANS CELL; NOTE; PATHOPHYSIOLOGY; PERMEABILITY; PROTEIN EXPRESSION; PSORIASIS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CARE; SKIN PROTECTION; STRATUM CORNEUM;

EID: 80052118399     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (68)

1. Bieber T, Prolss J. Atopic dermatitis. In: Gaspari AA, Tyring SK, eds. Clinical and Basic Immunodermatology. London: Springer-Verlag; 2008:193-206.
2. Elliott K, Forrest S. Genetic of atopic dermatitis. In: Bieber T, Leung DYM, eds. Atopic Dermatitis. New York: Marcel Dekker; 2002:81-110.
3. Schultz Larsen FV, Holm NV. Atopic dermatitis in a population based twin series: Concordance rates and heritability estimation. Acta Derm Venereol (Stockh). 1985;114(Suppl):159. (Pubitemid 15112175)
4. Strachan DP. Hay fever, hygiene, and household size. Br Med J. 1989;299:1259-1260. (Pubitemid 19280051)
5. Zutavern A, Hirsch T, Leupold W, et al. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy. 2005;35:1301-1308.
6. Williams H, Flohr C. How epidemiology has challenged three prevailing concepts about atopic dermatitis. J Allergy Clin Immunol. 2006;118:209-213. (Pubitemid 43949587)
7. Di Nardo A, Wetz PW. Atopic Dermatitis. In: Leyden JJ, Rawlings AV, eds. Skin Moisturization. 1st ed. New York: Marcel Dekker; 2002:165-178.
8. Del Rosso JQ. Understanding skin cleansers and moisturizers: The correlation of formulation science with the art of clinical use. Cosmet Dermatol. 2003;16:19-31.
9. Thune P. Evaluation of the hydration and the water-holding capacity in atopic skin and so-called dry skin. Acta Derm Venereol. 1989;144 (Suppl):133-135. (Pubitemid 19228734)
10. Proksch E, Elias PM. Epidermal barrier in atopic dermatitis. In: Bieber T, Leung DYM, eds. Atopic Dermatitis. New York: Marcel Dekker; 2002:123-143.
11. Tabata N, O'Goshi K, Zhen YX, et al. Biophysical assessment of persistent effects of moisturizers after their daily applications: Evaluation of corneotherapy. Dermatology. 2000;200:308-313. (Pubitemid 30451578)
12. Hanifin JM, Hebert AA, Mays SR, et al. Effects of a low-potency corticosteroid formulation plus a moisturizing regimen in the treatment of atopic dermatitis. Curr Therapeutic Res. 1998;59:227-233. (Pubitemid 28206661)
13. Boguniewicz M. Conventional topical treatment of atopic dermatitis. In: Bieber T, Leung DYM, eds. Atopic Dermatitis. New York: Marcel Dekker; 2002:453-477.
14. Lucky AW, Leach AD, Laskarzewski P, et al. Use of an emollient as a steroid sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol. 1997;14:321-324. (Pubitemid 27332923)
15. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;92(Suppl):44-47.
16. Diepgen TL, Fartsch M, Hornstein OP. Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and in the general population. Acta Derm Venereol (Stockh). 1989;144:50-54. (Pubitemid 19228714)
17. Williams HC, Pembrokle AC, Burney PGF, et al. Community validation of the UK Working Party's diagnostic criteria for atopic dermatitis. Br J Dermatol. 1996;135:12-17. (Pubitemid 26225107)
18. Schultz Larsen F, Diepgen T, Svensonn A. Clinical criteria in diagnosing AD: The Lillehammer criteria 1994. Acta Derm Venereol (Stockh). 1996;76(Suppl 196):115-119.
19. Wuthrich B, Schmid-Grendelmeier P. Definition and diagnosis of intrinsic versus extrinsic atopic dermatitis. Conventional topical treatment of atopic dermatitis. In: Bieber T, Leung DYM, eds. Atopic Dermatitis. New York: Marcel Dekker; 2002:1-20.
20. Paller AS, Mancini AJ. Exczematous eruptions in childhood. In: Paller AS, Mancini AJ, eds. Hurwitz Clinical Pediatric Dermatology, 3rd Edition. Philadelphia: Elsevier-Saunders; 2006:49-65.
21. Krafchik BR, Halbert A, Yamamoto K, Sasaki R. Atopic dermatitis. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology, 3rd Edition. Philadelphia: Mosby-Elsevier; 609-629.
22. Mallory SB, Bree A, Chern P, Eczematous dermatoses. In: Mallory SB, Bree A, Chern P, eds. Illustrated Manual of Pediatric Dermatology. Boca Raton, FL: Taylor & Francis; 2005:49-57.
23. Werfel T, Kapp A. What do we know about the epidemiology of the intrinsic type of atopic dermatitis? Curr Probl Dermatol. 1999;28:29-36.
24. Jensen-Jarolim E, Poulsen LK, With H, et al. Atopic dermatitis of the face, scalp, and neck: Type I reaction to the yeast Pityrosporum ovale? J Allergy Clin Immunol. 1992;89:44-51.
25. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832-836. (Pubitemid 38608590)
26. Elias PM. Physiologic lipids for barrier repair in dermatology. In: Draelos ZD, ed. Cosmeceuticals. 1st ed. Philadelphia: Elsevier-Saunders; 2005; 63-70.
27. Harding CR. The stratum corneum: Structure and function in health and disease. Derm Ther. 2004;17:6-15.
28. O'Regan GM, Sandilands A, McLean WHI, Irvine AD. J Allergy Clin Immunol. 2008;122:689-693.
29. Rawlings AV, Canestrari DA, Dobkowski B. Moisturizer technology versus clinical performance. Derm Ther. 2004;17:49-56.
30. McLean I. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol. 2008;128:2117-2119. (Pubitemid 352001213)
31. Imokawa G. Ceramides as natural moisturizing factors and their efficacy in dry skin. In: Leyden JJ, Rawlings AV, eds. Skin Moisturization. 1st ed. New York: Marcel Dekker; 2002:267-302.
32. Cook M, Danby S, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129:1892-1908.
33. Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol. 1995;75:429-433. (Pubitemid 26051887)
34. Imokawa G, Abe A, Higaki Y, et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin? J Invest Dermatol. 1991;96:523-526.
35. Schafer L, Kragballe K. Abnormalities in epidermal lipid metabolism in 11 patients with atopic dermatitis. J Invest Dermatol. 1991;96:10-15.
36. Yamamoto A, Serizawa S, Ito M, et al. Stratum corneum abnormalities in atopic dermatitis. Arch Dermatol Res. 1991;283:219-223.
37. Matsumoto Y, Hamashima H, Masuda K, et al. The antibacterial activity of plaunotol against Staphylococcus aureus isolated from the skin of patients with atopic dermatitis. Microbios. 1998;96:149-155. (Pubitemid 128557795)
38. DiNardo A, Wertz P, Gianetti A, et al. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol. 1998;78:27-30. (Pubitemid 28103674)
39. Choi MJ, Maibach HI. Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol. 2005;6:215-223. (Pubitemid 41159408)
40. Jin K, Higaki Y, Takagi Y, et al. Analysis of beta-clucocerebrosidase and ceramidase activities in atopic and aged dry skin. Acta Derm Venereol. 1994;74:337-340. (Pubitemid 24305843)
41. Doering T, Holleran WM, Potratz A, et al. Sphingolipid activator proteins are required for epidermal permeability barrier formation. J Biol Chem. 1999;274:11038-11045.
42. Cui CY, Kusuda S, Seguchi T, et al. Decreased level of propasin in atopic skin. J Invest Dermatol. 1997;109:319-323. (Pubitemid 27394645)
43. Hara J, Higuchi K, Okamoto R, et al. High-expression of sphingomyelin deacylase is an important determinant ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol. 2000;115:406-413.
44. Murata Y, Ogata J, Higaki Y, et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol. 1996;106:1242-1249. (Pubitemid 26195849)
45. Seguchi T, Cui CY, Kusuda S, et al. Decreased expression of filaggrin in in atopic skin. Arch Dermatol Res. 1996;288:442-446. (Pubitemid 26282737)
46. Vasilopoulos Y, Cork MJ, Murphy R, et al. Genetic association between AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol. 2004;123:62-66. (Pubitemid 38833464)
47. Ogawa H, Yoshiike TJ. A speculative view of atopic dermatitis: Barrier dysfunction in pathogenesis. Dermatol Sci. 1993;5:197-204. (Pubitemid 23265478)
48. Mar A, Tarn M, Jolley D, et al. The cumulative incidence of atopic dermatitis in the first 12 months among Chinese, Vietnamese, and Caucasians infants born in Melbourne, Australia. J Am Acad Dermatol. 1999;40:597-602. (Pubitemid 29153188)
49. Proksch E, Brasch J. Influence of epidermal permeability barrier disruption and Langerhans cell density on allergic contact dermatitis. Acta Derm Venereol. 1997;77:102-104. (Pubitemid 27201983)
50. Wollenberg A, Kraft S, Hanau D, et al. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol. 1996;106:446-453. (Pubitemid 26117582)
51. Novak N, Bieber T. The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J Am Acad Dermatol. 2005;53(Suppl 2):S171-S176. (Pubitemid 40966763)
52. Tupker RA, Pinnagoda J, Coenraads PJ, et al. Susceptibility to irritants: role of barrier function, skin dryness, and history of atopic dermatitis. Br J Dermatol. 1990;123:199-205.
53. Conti A, Di Nardo A, Seidenari S. No alteration of biophysical parameters in the skin of subjects with respiratory atopy. Dermatology. 1996;192:317-320.
54. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol. 2002;47:198-208.
55. Cerave Hydrating Cleanser, Cream, Lotion. Madison, NJ: Coria Laboratories/Valeant Pharmaceuticals; data on file.
56. Epiceram Topical Emulsion [package insert]. Bridgewater, NJ: Promius; 2010.
57. Hyalotopic Plus [package insert]. Cumberland, RI: Onset Dermatologics; 2010.
58. Cetaphil Restoraderm Moisturizer. Fort Worth, TX: Galderma Laboratories; data on file.
59. Cetaphil Restoraderm Body Wash. Fort Worth, TX: Galderma Laboratories; data on file.
60. Castiel-Higounenc I, Chopard M, Ferraris C. Stratum corneum lipids: Specificity, role, deficiencies and modulation. Oleagineux, Corps Gras, Lipides. 2004;11:401-406.
61. Eichenfield LF, McCollum A, Msika P. The benefits of sunflower oleodistillate (SOD) in pediatric dermatology. Pediatr Dermatol. 2009;26:669-675.
62. Piccardi N, Piccirilli A, Choulot JC, et al. Sunflower oil oleodistillate for atopy treatment: an in-vitro and clinical investigation. J Invest Dermatol. 2001;117:390-423.
63. Fowler J, Silverburg N. Active naturals have a key role in atopic dermatitis. Semin Cutan Med Surg. 2008;27(Suppl 3):8-10.
64. Maranz S, Wiesman Z, Garti N. Phenolic constituents of Shea (Vitellaria paradoxa) kernels. J Agric Food Chem. 2003;51:6268-6273.
65. Obeda M, Sousselier L. Shea butter: The revival of an African wonder. Global Cosmetic Ind. 1999;4:36-41.
66. Tanno O, Ota Y, Kitamura N, et al. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol. 2000;143:524-531.
67. Ghering W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Arzneim-Forsch/Drug Res. 2000;50:659-663. (Pubitemid 30490226)
68. Ebner F, Heller A, Rippke F, et al. Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol. 2002;3:427-433. (Pubitemid 34879434)